PROM1 and posterior cortical atrophy: Moreover, extended enzalutamide therapy enhances CD133 and ALDH1A1 expression in LNCaP cells and modulates transcriptional signaling in PCa cells by increasing Nanog and OCT4 expression, leading to the development of stem cell-like characteristics (Verma et al., 2020).